Pharmaceutical policy change and the safety of new drugs
Year of publication: |
2002
|
---|---|
Authors: | Olson, Mary K. |
Published in: |
The journal of law & economics. - Chicago, Ill. : Univ. of Chicago Press, ISSN 0022-2186, ZDB-ID 218304-3. - Vol. 45.2002, 2,2, p. 615-642
|
Subject: | Arzneimittel | Pharmaceuticals | Aufsichtsbehörde | Regulatory agency | Dauer | Duration | USA | United States | 1990-1995 |
-
The effect of FDA advisories on branded pharmaceutical firms' valuations and promotion efforts
Conti, Rena M., (2011)
-
The effects of pharmaceutical marketing and promotion on adverse drug events and regulation
David, Guy, (2010)
-
The effects of product liability exemption in the presence of the FDA
Philipson, Tomas J., (2011)
- More ...
-
Olson, Mary K., (2020)
-
Regulatory Reform and Bureaucratic Responsiveness to Firms: the Impact of User Fees in the FDA
Olson, Mary K., (2000)
-
Are novel drugs more risky for patients than less novel drugs?
Olson, Mary K., (2004)
- More ...